Multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
placebo cpasule,starch and sugar,bid for one month
Intervention 1: Frankincense,300 mg capsule ,oral,bid for one month. Intervention 2: placebo cpasule,starch and sugar,bid for one month.
Treatment - Drugs
Placebo
Frankincense,300 mg capsule ,oral,bid for one month
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:People 15 to 65 years old; Patients with urinary disorders; patients without any other neurological disease such as stroke or psychiatric disease such as depression; patients without diabetes or any Autoimmune diseases such as lupus; in the past month,patients had no new attack and they have not received corticosteroid; studied women must not be pregnant exclusion criteria:the emergence of side effects; disease new attack;not using medication for a week; urinary tract infection which will be determined by paraclinical tests
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary disorder. Timepoint: Before intervention and one month after intervention. Method of measurement: Incontinence Quality of Life Questionnaire (I-QOL). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: During intervention. Method of measurement: Incontinence Quality of Life Questionnaire (I--QOL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Omidinia
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed